HVRLZEKDTUEKQH-NEGCSKJWSA-N
HVRLZEKDTUEKQH-NEGCSKJWSA-N Basic information
- Product Name:
- HVRLZEKDTUEKQH-NEGCSKJWSA-N
- Synonyms:
-
- HVRLZEKDTUEKQH-NEGCSKJWSA-N
- [2H3]- Olopatadine Hydrochloride
- 2-[(11Z)-11-[3-[methyl(trideuteriomethyl)amino]propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
- CAS:
- 1331635-21-2
- MF:
- C21H21ClD3NO3
- MW:
- 376.891645334
- Mol File:
- 1331635-21-2.mol
HVRLZEKDTUEKQH-NEGCSKJWSA-N Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- Methanol: Slightly soluble,
- form
- A solid
- Water Solubility
- Water: Slightly soluble
HVRLZEKDTUEKQH-NEGCSKJWSA-N Usage And Synthesis
Uses
Labelled Olopatadine. Dual acting histamine H1-receptor antagonist and mast cell stabilizer. Antiallergic; antihistaminic.
Biological Activity
Olopatadine-d3 is intended for use as an internal standard for the quantification of olopatadine by GC- or LC-MS. Olopatadine is a histamine H1 receptor antagonist (Ki =41 nM).1 It is 1,059- and 4,177-fold selective for histamine H1 over H2 and H3 receptors, respectively. Olopatadine inhibits histamine-induced phosphoinositide turnover in isolated human conjunctival epithelial cells, isolated human corneal fibroblasts, and human trabecular meshwork (TM3) cells (IC50s = 9.5, 19, and 39.9 nM, respectively). In vivo, olopatadine inhibits passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and IgG1-mediated bronchoconstriction in ovalbumin-sensitized guinea pigs (ED50 = 30 μg/kg).2 Formulations containing olopatadine have been used in the treatment of allergic rhinitis and conjunctivitis, as well as in the treatment of itch in patients with well-controlled urticaria.
References
1.Sharif, N.A., Xu, S.X., and Yanni, J.M.Olopatadine (AL-4943A): Ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitisJ. Ocul. Pharmacol. Ther.12(4)401-407(1996) 2.Ohshima, E., Otaki, S., Sato, H., et al.Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivativesJ. Med. Chem.35(11)2074-2084(1992)
HVRLZEKDTUEKQH-NEGCSKJWSA-NSupplier
- Tel
- 021-58432009 400-005-6266
- marketing1@energy-chemical.com
- Tel
- 18661161657
- yaoxiangqiu2021@163.com
- Tel
- 18818260767
- 2625930290@qq.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Tel
- 17301488900
- judy.xia@synzest.com
HVRLZEKDTUEKQH-NEGCSKJWSA-N(1331635-21-2)Related Product Information
- 2-[(4-METHYLPHENOXY)METHYL]BENZOIC ACID
- (E)-Olopatadine Hydrochloride
- 3-((Dimethylamino)propyl)triphenylphosphonium bromide
- Olopatadine Impurity 11 HBr
- Olopatadine Impurity 5
- Olopatadine-d3 N-Oxide
- N-DesMethyl Olopatadine
- 1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl-
- Olopatadine Impurity 9
- Olopatadine Amide
- Isohexyltriphenylphosphonium Bromide
- α-Hydroxy Olopatadine
- Olopatadine Impurity 29
- Olopatadine Impurity 4
- (E)-Olopatadine-O-methyl
- N-DesMethyl Olopatadine Methyl Ester Trifluoroacetic Acid Salt
- 1253107-27-5
- (Z)-[4-[2-(4-Dimethylaminobut-1-enyl)benzyloxy]-3-iodophenyl]acetic Acid Methyl Ester